XML 38 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Series C Preferred Stock
Preferred stock
Common stock
Retained earnings
Retained earnings
Series C Preferred Stock
Accumulated other comprehensive income (loss)
Sempra shareholders' equity
Sempra shareholders' equity
Series C Preferred Stock
Non- controlling interests
Beginning Balance at Dec. 31, 2022 $ 29,256   $ 889 $ 12,160 $ 14,201   $ (135) $ 27,115   $ 2,141
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 1,172       980     980   192
Other comprehensive income (loss) (93)           (47) (47)   (46)
Share-based compensation expense 17     17       17    
Dividends declared:                    
Preferred dividends   $ (11)       $ (11)     $ (11)  
Common stock dividends declared (374)       (374)     (374)    
Repurchases of common stock (31)     (31)       (31)    
Noncontrolling interest activities:                    
Contributions 97                 97
Distributions (43)                 (43)
Sale 255     18       18   237
Ending balance at Mar. 31, 2023 30,245   889 12,164 14,796   (182) 27,667   2,578
Beginning Balance at Dec. 31, 2023 33,654 [1]   889 12,204 15,732   (150) 28,675   4,979
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 881       812     812   69
Other comprehensive income (loss) 161           46 46   115
Share-based compensation expense 21     21       21    
Dividends declared:                    
Preferred dividends   $ (11)       $ (11)     $ (11)  
Common stock dividends declared (392)       (392)     (392)    
Issuances of common stock 24     24       24    
Repurchases of common stock (40)     (40)       (40)    
Noncontrolling interest activities:                    
Contributions 474                 474
Distributions (111)                 (111)
Ending balance at Mar. 31, 2024 $ 34,661   $ 889 $ 12,209 $ 16,141   $ (104) $ 29,135   $ 5,526
[1] Derived from audited financial statements.